Navigation Links
Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
Date:3/28/2013

maintained it for two or more weeks. In addition, the bioavailability and pharmacokinetics observed in both species are expected to support subcutaneous administration in patients at a frequency of once weekly, bi-monthly or possibly at even longer intervals. The only currently approved complement inhibitor requires an intravenous infusion lasting 30 minutes or longer in the hospital or doctor's office.  Subcutaneous dosing avoids the complexity and inconvenience of intravenous infusion and would allow patients to self-administer OMS721 at home.

"As we wrap up our CTA-enabling studies, OMS721 continues to impress with its potential competitive advantages, including subcutaneous administration, convenient dosing, and maintenance of the acquired immune response to infection," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "OMS721 holds significant promise to treat a wide range of immune-related disorders, and today's data further underscore the commercial opportunities for OMS721.  We plan to focus initially on aHUS, a rare and life-threatening indication seen most commonly in children. Submission of our CTA is expected next quarter, and we look forward to evaluating the drug product soon in clinical trials."

About Omeros' MASP-2 Program

Omeros controls the worldwide rights to MASP-2 and all therapeutics targeting MASP-2, a novel pro-inflammatory protein target involved in activation of the complement system, which is an important component of the immune system. The complement system plays a role in the inflammatory response and becomes activated as a result of tissue damage or microbial infection. MASP-2 appears to be unique to, and required for the function of, one of the principal complement activation pathways, known as the lectin pathway. Importantly, inhibition of MASP-2 does not appear to interfere with the antibody-dependent classical complement activation pathwa
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... officer, will present at the CL King 13 th ... 10, 2015 at 11:00 a.m. ET. The conference will ... New York City . ...
(Date:9/3/2015)... , Sept. 3, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Wells Fargo Healthcare Conference at 8:50 a.m. ET on ... 9-10, 2015 at The Hyatt Regency, Boston ...
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
Breaking Medicine Technology:HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4
... Sept. 27, 2011 BD Biosciences, a segment of ... of the new BD Falcon™ Multi-Flask, a multi-layer cell ... cell culture easily and more efficiently. ... flasks. The new BD Falcon Multi-Flask, available in both ...
... Sept. 27, 2011 Thousands of jobs in Ohio ... if harmful policies – such as imposing new taxes ... by federal policymakers. From research to technical ... suppliers to child care services, the biopharmaceutical sector supports ...
Cached Medicine Technology:BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 3
(Date:9/3/2015)... ... September 03, 2015 , ... ... the release of her debut book, “Stop Wasting Your Time Blaming Others for ... (September 6), Hartley’s guide to overcoming life’s obstacles by taking full responsibility for ...
(Date:9/3/2015)... ... ... The Linda Hall Library 2015 Fall Lecture Series will give ... at the South Pole, and the interior of life-extending stem cells – educating ... foremost independently funded research library devoted to science, engineering, and technology, will feature the ...
(Date:9/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national chief executive officer recruitment for Melissa Memorial Hospital in Holyoke, ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:9/3/2015)... ... 2015 , ... Global Vision , the world leader in the development ... print and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... London, booth #F33 , Be the first to get a sneak peek of Intelligent ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... DiabetesSisters is pleased to announce the additional of Carol Wysham, MD, to their ... board members Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea ...
Breaking Medicine News(10 mins):Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2
... sure-fire test exists, experts say, , FRIDAY, Oct. 2 (HealthDay ... made, the earlier treatment can begin. On that, experts agree. ... predict your odds of developing the degenerative brain disorder -- ... than ever to figure it out: Do you or don,t ...
... 2 Brent Phillips, a senior executive at Mayo ... of Aurora Medical Group. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) ... 960-physician medical group. , "Brent will be ... Bailet, M.D., president of Aurora Medical Group. "He ...
... blood cell activity increases in these patients when oral hygiene ... -- Black males may be at increased risk for heart ... finds. , Indiana University School of Dentistry researchers studied 128 ... buildup of dental plaque didn,t cause a change in total ...
... mental health disorders in this country has nearly doubled in ... patients? Clinical psychologists and therapists are charged with the task, ... out of date and lack scientific rigor. This is in ... Psychology (PsyD) programs and for-profit training centersare not grounded in ...
... , Highlights remarkable history, role of dentists and reaffirms ... American Dental Association (ADA) yearlong observance of its 150th birthday ... Stars," at the Waikiki Shell. , "The ADA,s 150th anniversary ... profession and our Association," said ADA President John S. Findley, ...
... bestow highest honor on Kenneth L. Kalkwarf, D.D.S. at its ... The American Dental Association (ADA) will honor Kenneth L. Kalkwarf, ... Annual Session and World Marketplace Exhibition in Honolulu. The Distinguished ... an individual. , ADA President John S. Findley, ...
Cached Medicine News:Health News:Uncertainty Surrounds Testing for Alzheimer's 2Health News:Uncertainty Surrounds Testing for Alzheimer's 3Health News:Mayo Clinic Executive Brent Phillips to Join Aurora Medical Group as Chief Operating Officer 2Health News:Dental Plaque Buildup May Raise Heart Risk in Black Men 2Health News:Where's the science? The sorry state of psychotherapy 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 3Health News:Dental Educator to Receive the ADA Distinguished Service Award 2Health News:Dental Educator to Receive the ADA Distinguished Service Award 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... The PowerLab/4SP is a high-performance data acquisition ... research applications including human and animal physiology, ... engineering. The unit is capable of recording ... (up to 200 000 samples per second ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: